SCHEMBL1825398

SCHEMBL1825398

COc1cccc(C2CC3CCC(C2)N3C(=O)c2ccc3c(c2)OCCO3)c1

nearest known ligand 0.53

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ NPC1 O15118 3/20 0.53
▸ RAB9A P51151 3/20 0.53
▸ PKM P14618 2/20 0.53
▸ CTNNB1 P35222 2/20 0.53
▸ WNT3A P56704 2/20 0.53
▸ RXFP1 Q9HBX9 4/20 0.46
▸ BLM P54132 1/20 0.46
▸ SMN1; SMN2 Q16637 3/20 0.45
▸ TSHR P16473 2/20 0.45
▸ HPGD P15428 1/20 0.45
▸ PLK1 P53350 1/20 0.45
▸ LMNA P02545 3/20 0.43
▸ KDM4E B2RXH2 2/20 0.43
▸ TP53 P04637 1/20 0.43
▸ NFKB1 P19838 1/20 0.43
▸ NFKB2 Q00653 1/20 0.43
▸ RELA Q04206 1/20 0.43
▸ ALDH1A1 P00352 1/20 0.43
▸ F2 P00734 1/20 0.42
▸ CYP1A2 P05177 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL10244105 1.00 NPC1 (0.53) NPC1RAB9APKMCTNNB1WNT3A
SCHEMBL10243942 0.89 SMN1; SMN2 (0.51) NPC1RAB9APKMCTNNB1WNT3A
SCHEMBL17350576 0.89 SMN1; SMN2 (0.51) NPC1RAB9APKMCTNNB1WNT3A
SCHEMBL10243840 0.89 SMN1; SMN2 (0.51) NPC1RAB9APKMCTNNB1WNT3A
SCHEMBL10243790 0.85 MGLL (0.53) NPC1CTNNB1RXFP1SMN1; SMN2TSHR
SCHEMBL2682992 0.85 MGLL (0.53) NPC1CTNNB1RXFP1SMN1; SMN2TSHR
SCHEMBL10243986 0.85 ALDH1A1 (0.54) NPC1RAB9APKMCTNNB1SMN1; SMN2
SCHEMBL2682674 0.85 ALDH1A1 (0.54) NPC1RAB9APKMCTNNB1SMN1; SMN2
SCHEMBL10244017 0.83 TSHR (0.53) SMN1; SMN2TSHRHPGDALDH1A1
SCHEMBL10243879 0.83 ALDH1A1 (0.48) NPC1RAB9APKMCTNNB1SMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2318403-B1 Aryl- and heteroarylcarbonyl derivatives of substituted nortropanes, medicaments containing such compounds and their use BOEHRINGER INGELHEIM INT (DE) 2015-12-23 — — EP disclosed
US-8609690-B2 Aryl- and heteroarylcarbonyl derivatives of substituted nortropanes, medicaments containing such compounds and their use BOEHRINGER INGELHEIM INTERNATIONAL GMBH (DE) 2013-12-17 — — US disclosed
US-20120115853-A1 Aryl- and Heteroarylcarbonyl derivatives of substituted nortropanes, medicaments containing such compounds and their use BOEHRINGER INGELHEIM INTERNATIONAL GMBH (DE) 2012-05-10 — — US disclosed
EP-2318403-A1 ARYL- AND HETEROARYLCARBONYL DERIVATIVES OF SUBSTITUTED NORTROPANES, MEDICAMENTS CONTAINING SUCH COMPOUNDS AND THEIR USE Boehringer Ingelheim International GmbH (DE) 2011-05-11 — — EP disclosed
WO-2010023161-A1 ARYL- AND HETEROARYLCARBONYL DERIVATIVES OF SUBSTITUTED NORTROPANES, MEDICAMENTS CONTAINING SUCH COMPOUNDS AND THEIR USE BOEHRINGER INGELHEIM INTERNATIONAL GMBH (DE) 2010-03-04 — — WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20120115853-A1 Aryl- and Heteroarylcarbonyl derivatives of substituted nortropanes, medicaments containing such compounds and their use HSD11B1, HSD11B2, HSD17B1 NPC1 136/4885RAB9A 4154/4885PKM 2761/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback